Laurus Labs Ltd

NSE: LAURUSLABS · BSE: 540222 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹2,007.00
Market cap: ₹1,08,441 Cr
Revenue (annual): ₹6,813 Cr
Net profit (annual): ₹888.8 Cr
P/E (TTM): 99.2×Sector 50.4×
Promoter holding: 27.47%-0.02% QoQ
FII holding: 28.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Sep 2026 18:21 IST BSE

Earnings Call

Laurus Labs Investor Presentation: Key Takeaways

Laurus Labs delivered record Q1FY27 revenue of ₹2,026 Cr, a 29% YoY increase, driven by robust CDMO growth. EBITDA margins expanded 700 bps YoY to 31.8% on favorable mix.

Open call summary → Read the filing ↗